Evaluation of Cobas 8000 Analyzer Series Module e801 Analytical Performance.

Area of Science:

• Clinical Chemistry
• Laboratory Medicine
• Diagnostic Assays

Background:

• Immunoassays are crucial for patient care, providing vital diagnostic information.
• The Cobas 8000 series features the e801, an automated immunoassay system utilizing streptavidin-biotin technology.
• Evaluating the analytical performance of new diagnostic systems is essential for clinical adoption.

Purpose of the Study:

• To assess the analytical performance of the Cobas 8000 e801 automated immunoassay system.
• To validate the precision, linearity, assay comparison, and reference range of 16 key analytes on the e801 analyzer.
• To determine the suitability of the e801 for routine clinical laboratory use.

Main Methods:

• Analytical performance was evaluated according to Clinical Laboratory Standards Institute guidelines.
• Precision, linearity, assay comparison, and reference range validation were assessed for 16 analytes.
• Statistical analyses included coefficients of variation, correlation coefficients (r), and r-squared values (r²).

Main Results:

• All 16 analytes demonstrated coefficients of variation below allowable total error, indicating high precision.
• Excellent linearity was confirmed for all analytes across the tested analytical range (r²≥0.99).
• Assay comparisons showed high correlation (r>0.975) between the e801 and existing systems, with validated reference ranges meeting criteria.

Conclusions:

• The Cobas 8000 e801 analyzer exhibits acceptable analytical performance for precision, linearity, and correlation.
• The e801 system is deemed suitable for routine immunoassays in clinical settings.
• Awareness and education regarding potential biotin interference are recommended for optimal implementation.